NSEGeneral Updates16 Oct 2026 · 16 Oct 2026, 04:58 pm
General Updates
Zydus Lifesciences Limited · ZYDUSLIFE
✦ AI SummaryESG
Zydus Lifesciences Limited has informed the Exchange about General Updates ESG Rating. The company has received an overall ESG rating of 71 from NSE Sustainability Ratings and Analytics Limited, a subsidiary of NSE Indices Limited, for the financial year 2026, which is categorized as 'leader'. The report was received via email on October 15, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Zydus Lifesciences Limited has informed the Exchange about General Updates ESG Rating
Attachments (1)
📄pdf
Download →
Cadilahc_16102026165747_SEIntimationESGRating16102026.pdf
View document text
October 16, 2026
BSE Limited Code: 532321
1st Floor,
P J Towers,
Dalal Street,
Mumbai-400001
Na(cid:415)onal Stock Exchange of India Limited Code: Zyduslife
Exchange Plaza, 5th Floor,
Plot No. C/1, G Block,
Bandra-Kurla Complex, Bandra (East),
Mumbai-400051
Sub.: ESG Ra(cid:415)ng
Ref.: Disclosure under regula(cid:415)on 30 read with Schedule III of SEBI (Lis(cid:415)ng Obliga(cid:415)ons and Disclosure
Requirements) Regula(cid:415)ons, 2015 (“the Lis(cid:415)ng Regula(cid:415)ons”) and SEBI Master Circular dated
January 30, 2026 (“the SEBI Master Circular”)
Dear Sir / Madam,
This is to inform that NSE Sustainability Ra(cid:415)ngs and Analy(cid:415)cs Limited (“NSRAL”), a subsidiary of NSE
Indices Limited and a group company of Na(cid:415)onal Stock Exchange of India Limited, a SEBI registered
ESG Ra(cid:415)ng Provider, has assigned overall ESG ra(cid:415)ng of 71 to the Company for the financial year 2026,
which is covered under category of ‘leader’.
The report was received by way of an email on October 15, 2026, at 17.29 hours.
Please note that this is an unsolicited ra(cid:415)ng and NSRAL has independently prepared the report based
on data pertaining to the Company available in public domain.
This disclosure is made in compliance with the provisions of regula(cid:415)on 30 of the Lis(cid:415)ng Regula(cid:415)ons
read with the SEBI Circular.
Thanking you,
Yours faithfully,
For, Zydus Lifesciences Limited
Dhaval N. Soni
Company Secretary and Compliance Officer
Membership No. FCS7063